The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
about
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceMechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.Evaluation of the clinical microbiology profile of moxifloxacin.Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.Mechanism of action of and resistance to quinolones.Activity of and resistance to moxifloxacin in Staphylococcus aureus.A new antibiotic with potent activity targets MscL.Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group.In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin.Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.Possible paths and potential barriers to successfully modeling drug resistance.
P2860
Q28361569-5C2D521F-127B-4CC6-84EC-8A0F74080B60Q34183514-AB0B08A0-9F3D-46E6-89EF-24F9F3D90518Q34183540-B7D93D1E-C792-4780-963B-B84E326CBD53Q34240856-5858E8E4-277A-400F-80B9-3681288FEB9CQ34408434-2470A28A-148C-44F2-9F37-3E516AB83806Q34885313-30070DE2-788D-4D26-8DC9-72C3999FB662Q35602329-C887C01D-D654-4441-9147-A8402AD743A2Q35626961-FF16FBD5-FDC2-42CB-A10A-ED9FFEDDD9D3Q39472413-C7E47428-80A4-4F64-8B70-EF278E4976CFQ39476686-79DE1FA5-1B31-4F7B-9880-E6E9BEE41CC7Q39776135-D8B9088E-0712-4CF0-8E0A-D29B80A9EBD9Q40799670-B284BC22-6704-4E82-9E25-3BC53F1F6809Q43833882-7305A74A-9236-410C-9760-A64FA1BC02AA
P2860
The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@en
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@nl
type
label
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@en
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@nl
prefLabel
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@en
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@nl
P2093
P356
P1476
The effect of moxifloxacin on ...... oli and Staphylococcus aureus.
@en
P2093
Schedletzky H
Wiedemann B
P356
10.1093/JAC/43.SUPPL_2.31
P407
P478
43 Suppl B
P577
1999-05-01T00:00:00Z